Can Fite BioPharma : Financial results for the six months ended June 30, 2023 and updates on its drug development programs and an unaudited interim condensed consolidated financial statements as of June 30, 2023. -Today at 09:30 am
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of...